Loading company…
Xianju Cuize develops pulmonary medicines and inhalation formulations.
Xianju Cuize develops therapies for perioperative and pulmonary conditions using extended-release and inhalation powder technology. Its spray-freeze-drying process is intended to improve the bioavailability of poorly water-soluble drugs for dry powder inhalation. Founded in 2019, the company is based in Hangzhou, China. It completed a strategic investment from Goldport Capital in May 2023.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in